Device manufacturers ponder CEE (Central and Eastern Europe) market entry timing
This article was originally published in Clinica
Many manufacturers of medical devices and diagnostics will prefer to wait until the central and eastern European countries accede to the European Union before entering those markets. But some may decide that now is the time to establish market presence ahead of the competition, and to face the challenges of the current regulations. Amanda Maxwell reports.
You may also be interested in...
In joint complaint, the FTC and New York Attorney General allege scheme to block generic Daraprim and maintain exorbitant list price; they cite hundreds of emails the incarcerated Shkreli has exchanged with co-defendant in last six months.
Biogen value-based contract with UPMC Health Plan ties payments to patient-reported outcomes for Tecfidera and Avonex. The company may seek something similar for Vumerity.
As interest in immune/inflammatory disease increases and savings achieved dip, payer focus on patient-reported outcomes for contracts reflects shift in focus, Avalere survey suggests.